Robert is our Chief Inclusion & Diversity Officer and is responsible for leading the firm’s Inclusion & Diversity strategy and ensuring this remains a key focus for the firm. Robert is also a patent attorney and the majority of Robert’s work is in the biopharma sector, principally with companies undertaking drug discovery and development. He advises on all stages of a medicine’s lifecycle, from initial discovery through clinical trials to regulatory approval. Working closely with in-house IP teams and scientists, he has extensive experience of drafting and prosecution, global portfolio management and invention capture. He also helps clients negotiate IP agreements and performs due diligence.
